RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma

OBJECTIVE: The RAD51 assay is a recently developed functional assay for homologous recombination deficiency (HRD) that reflects real-time HRD status. We aimed to identify the applicability and predictive value of RAD51 immunohistochemical expression in pre- and post-neoadjuvant chemotherapy (NAC) sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyeongmin, Kim, Se Hoon, Lee, Jung-Yun, Kim, Yoo-Na, Lee, Seung-Tae, Park, Eunhyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323304/
https://www.ncbi.nlm.nih.gov/pubmed/36807748
http://dx.doi.org/10.3802/jgo.2023.34.e45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323304/
https://www.ncbi.nlm.nih.gov/pubmed/36807748
http://dx.doi.org/10.3802/jgo.2023.34.e45

Ejemplares similares